Grey Matter Neurosciences
Developing a portable, precise ultrasound helmet to restore brain function in seniors.
Related Content
Grey Matter Neurosciences is a Toronto-based neurotechnology company focused on developing treatments for age-related brain disorders. The company is advancing a portfolio of medical devices and drug-device combinations, with a primary focus on Alzheimer's disease.
The company has secured a license for a focused ultrasound technology from the Sunnybrook Research Institute. This technology is the basis for an ultrasound headset currently in development. The company's efforts are supported by a recent $14 million seed financing round, which will be used to advance the treatment for Alzheimer's disease.
The company's business model is centered on the commercialization of its proprietary medical devices. The target market includes healthcare providers and patients in the neurology and geriatrics sectors.
Keywords: neurotechnology, medical devices, Alzheimer's disease, focused ultrasound, drug-device combinations, brain health, age-related diseases, neurodegenerative disorders, medical treatment, healthcare technology.